Orange Book product · Brand (NDA)
TRAVATAN Z
TRAVOPROST
At a glance
Sep 21, 2006
Approved
Brand (NDA)
Application
AT2
TE code
3
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Sep 21, 2006
20 yr ago
Today
Patent 8323630 expires
Listed drug product patent expiration.
Sep 20, 2027
in 1 yr 3 mo
Patent 8388941 expires
Listed drug product patent expiration.
Sep 20, 2027
in 1 yr 3 mo
Patent 8268299 expires
Listed drug product patent expiration.
Oct 13, 2029
in 3 yr 4 mo
Pharmaceutical detail
Active ingredient
TRAVOPROST
Strength
0.004%
Dosage form
SOLUTION/DROPS
Route
OPHTHALMIC
TE code
AT2
Application
NDA 021994
Product number
001
Marketing status
RX
Reference listed drug (RLD)
Yes
Reference standard (RS)
Yes
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 2023IDOSE TRBrand (NDA)
NDA 218010 · GLAUKOS
- 2014IZBABrand (NDA)
NDA 204822 · NOVARTIS
- 2001TRAVATANBrand (NDA)
NDA 021257 · ALCON PHARMS LTD
- 2025TRAVOPROSTGeneric (ANDA)
ANDA 214687 · ALEMBIC
- 2024TRAVOPROSTGeneric (ANDA)
ANDA 217228 · SOMERSET THERAPS LLC
- 2024TRAVOPROSTGeneric (ANDA)
ANDA 218159 · GLAND
- 2024TRAVOPROSTGeneric (ANDA)
ANDA 207040 · LUPIN
- 2021TRAVOPROSTGeneric (ANDA)
ANDA 203767 · MICRO LABS
- 2019TRAVOPROSTGeneric (ANDA)
ANDA 210458 · ALEMBIC
- 2017TRAVOPROSTGeneric (ANDA)
ANDA 205050 · MYLAN
- 2015TRAVOPROSTGeneric (ANDA)
ANDA 203431 · APOTEX
- 2013TRAVOPROSTGeneric (ANDA)
ANDA 091340 · CHARTWELL RX
Listed patents (3)
| Patent | Expires | In | Type |
|---|---|---|---|
| 8323630 | Sep 20, 2027 | in 1 yr 3 mo | Product |
| 8388941 | Sep 20, 2027 | in 1 yr 3 mo | Product |
| 8268299 | Oct 13, 2029 | in 3 yr 4 mo | Product |

